首页>
外国专利>
Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer
Nanoliposomal Irinotecan for Use in Treating Small Cell Lung Cancer
展开▼
机译:纳米脂质体伊立替康用于治疗小细胞肺癌
展开▼
页面导航
摘要
著录项
相似文献
摘要
Novel therapies for the treatment of small cell lung cancer (SCLC) include the administration of an antineoplastic therapy consisting of liposomal irinotecan administered once every two weeks, optionally including the administration of other non-antineoplastic agents to the patient such as the administration of a corticosteroid and an anti-emetic to the patient prior to the administration of the irinotecan liposome.
展开▼